Bio Farma - Indonesia is a state-owned company specializing in the production of vaccines and sera. Founded by the Dutch Government on August 6, 1890, in Jakarta as PARC VACCINOGEN, it later shifted its production center to Bandung in 1923, adjacent to the Hasan Sadikin Hospital. During the Japanese occupation of the Dutch East Indies (1942 - 1945), it was taken over by the Japanese Government and renamed BANDUNG BOEKI KENKYUSHOO, continuing its vaccine and serum production activities.
Following Indonesia's independence, the institution transitioned to the ownership of the Indonesian Government in 1946, with Dr. R.M. Sardjito leading the organization. Over time, it underwent several name changes, including State Company Pasteur, General Company Bio Farma, and now PT Bio Farma (Persero).
Bio Farma's product portfolio includes BCG vaccine, DTP-HB vaccine, DT vaccine, Td vaccine, Hepatitis B vaccine, Polio vaccine, Measles vaccine, Influenza vaccine, anti-snake venom serum, anti-diphtheria serum, and anti-tetanus serum. As a state-owned enterprise, Bio Farma is dedicated to fulfilling domestic vaccine needs. The excess capacity is exported to 117 countries.
Founded: 1890 Industries: Biotechnology, Health Care Headquarter: Indonesia Last Investment: No information available Last Investment Investors: No information available
There is no investment information
No recent news or press coverage available for Bio Farma - Indonesia.
We care about your data, and we'd love to use cookies make your experience better.
